- Home
- HWH vs EVGN Comparison
HWH vs EVGN Comparison
Compare HWH & EVGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HWH
- EVGN
- Stock Information
- Founded
- HWH 2021
- EVGN 1999
- Country
- HWH United States
- EVGN Israel
- Employees
- HWH N/A
- EVGN N/A
- Industry
- HWH Other Pharmaceuticals
- EVGN Agricultural Chemicals
- Sector
- HWH Health Care
- EVGN Industrials
- Exchange
- HWH Nasdaq
- EVGN Nasdaq
- Market Cap
- HWH 10.1M
- EVGN 11.6M
- IPO Year
- HWH N/A
- EVGN N/A
- Fundamental
- Price
- HWH $3.13
- EVGN $1.27
- Analyst Decision
- HWH
- EVGN Strong Buy
- Analyst Count
- HWH 0
- EVGN 1
- Target Price
- HWH N/A
- EVGN $3.50
- AVG Volume (30 Days)
- HWH 19.2M
- EVGN 47.1K
- Earning Date
- HWH 11-11-2025
- EVGN 08-19-2025
- Dividend Yield
- HWH N/A
- EVGN N/A
- EPS Growth
- HWH N/A
- EVGN N/A
- EPS
- HWH N/A
- EVGN N/A
- Revenue
- HWH $1,238,173.00
- EVGN $9,444,000.00
- Revenue This Year
- HWH N/A
- EVGN N/A
- Revenue Next Year
- HWH N/A
- EVGN $63.64
- P/E Ratio
- HWH N/A
- EVGN N/A
- Revenue Growth
- HWH 17.28
- EVGN N/A
- 52 Week Low
- HWH $0.90
- EVGN $0.95
- 52 Week High
- HWH $7.77
- EVGN $3.32
- Technical
- Relative Strength Index (RSI)
- HWH 52.90
- EVGN 50.50
- Support Level
- HWH $2.82
- EVGN $1.21
- Resistance Level
- HWH $7.16
- EVGN $1.31
- Average True Range (ATR)
- HWH 1.18
- EVGN 0.06
- MACD
- HWH -0.00
- EVGN 0.00
- Stochastic Oscillator
- HWH 28.06
- EVGN 64.71
About HWH HWH International Inc.
HWH International Inc is and its consolidated subsidiaries operate a food and beverage business in Singapore and South Korea. The F&B business operates four cafes, two of which are located in South Korea and two in Singapore, as well as an online healthy food store, serving customers in Singapore.
About EVGN Evogene Ltd
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the Agriculture segment, followed by Industry.